ethyl 2-(dimethoxyphosphoryl)butanoate | 1076236-52-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: ethyl 2-(dimethoxyphosphoryl)butanoate
• 英文别名: ethyl 2-(dimethoxyphosphoryl)butanonate；Ethyl 2-dimethoxyphosphorylbutanoate
• CAS: 1076236-52-6
• 化学式: C₈H₁₇O₅P
• 分子量: 224.194
• InChiKey: ANHGPXXCGSQOAF-UHFFFAOYSA-N

物化性质

• 沸点：
  281.5±23.0 °C(Predicted)
• 密度：
  1.113±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  61.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  丙酮酸乙酯 、 ethyl 2-(dimethoxyphosphoryl)butanoate 在 sodium hydride 作用下， 以 乙二醇二甲醚 为溶剂， 以87.2%的产率得到diethyl 2-ethyl-3-methylmaleate
  参考文献：
  名称：

  [EN] SUBSTITUTED AZOLE DIONE COMPOUNDS WITH ANTIVIRAL ACTIVITY
  [FR] COMPOSÉS AZOLE DIONE SUBSTITUÉS À ACTIVITÉ ANTIVIRALE

  摘要：

  本文提供了使用替代咪唑二酮化合物治疗病毒感染的方法。

  公开号：

  WO2021194954A1

文献信息

• Compounds with anti-cancer activity
  申请人：Kawabe Takumi

  公开号：US20080275057A1

  公开（公告）日：2008-11-06

  Novel substituted azole diones are provided that kill cells, suppress cell proliferation, suppress cell growth, abrogate the cell cycle G2 checkpoint and/or cause adaptation to G2 cell cycle arrest. Methods of making and using the invention compounds are provided. The invention provides substituted azole diones to treat cell proliferation disorders. The invention includes the use of substituted azole diones to selectively kill or suppress cancer cells without additional anti-cancer treatment. The invention includes the use of cell cycle G2-checkpoint-abrogating substituted azole diones to selectively sensitize cancer cells to DNA damaging reagents, treatments and/or other types of anti-cancer reagents.

  提供了一种新型的取代咪唑二酮，可以杀死细胞，抑制细胞增殖，抑制细胞生长，废除细胞周期G2检查点和/或导致对G2细胞周期阻滞的适应。提供了制备和使用该发明化合物的方法。该发明提供了取代咪唑二酮来治疗细胞增殖紊乱。该发明包括使用取代咪唑二酮来选择性地杀死或抑制癌细胞，而无需额外的抗癌治疗。该发明包括使用细胞周期G2检查点废除的取代咪唑二酮来选择性地使癌细胞对DNA损伤试剂、治疗和/或其他类型的抗癌试剂产生敏感性。
• COMPOUNDS WITH ANTI-CANCER ACTIVITY
  申请人：KAWABE TAKUMI

  公开号：US20110092514A1

  公开（公告）日：2011-04-21

  Novel substituted azole diones are provided that kill cells, suppress cell proliferation, suppress cell growth, abrogate the cell cycle G2 checkpoint and/or cause adaptation to G2 cell cycle arrest. Methods of making and using the invention compounds are provided. The invention provides substituted azole diones to treat cell proliferation disorders. The invention includes the use of substituted azole diones to selectively kill or suppress cancer cells without additional anti-cancer treatment. The invention includes the use of cell cycle G2-checkpoint-abrogating substituted azole diones to selectively sensitize cancer cells to DNA damaging reagents, treatments and/or other types of anti-cancer reagents.

  本发明提供了一种替代的咪唑二酮，可以杀死细胞、抑制细胞增殖、抑制细胞生长、废除细胞周期G2检查点和/或导致适应G2细胞周期停滞。本发明提供了制备和使用该发明化合物的方法。该发明提供了替代的咪唑二酮来治疗细胞增殖障碍。该发明包括使用替代的咪唑二酮选择性地杀死或抑制癌细胞，而不需要额外的抗癌治疗。该发明包括使用细胞周期G2检查点废除的替代的咪唑二酮，以选择性地使癌细胞对DNA损伤试剂、治疗和/或其他类型的抗癌试剂敏感。
• COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER
  申请人：CanBas Co., Ltd.

  公开号：EP3088397A1

  公开（公告）日：2016-11-02

  Substituted azole diones (II) and (III) are provided that kill cells, suppress cell proliferation, suppress cell growth, abrogate the cell cycle G2 checkpoint and/or cause adaptation to G2 cell cycle arrest. Methods of making the invention compounds are provided. The invention provides substituted azole diones (II) and (III) to treat cell proliferation disorders. The invention includes the substituted azole diones (II) and (III) for use to selectively kill or suppress cancer cells without additional anti-cancer treatment. The invention includes the cell cycle G2- checkpoint-abrogating substituted azole diones (II) and (III) for use to selectively sensitize cancer cells to DNA damaging reagents, treatments and/or other types of anti-cancer reagents.

  本发明提供的取代唑二酮类化合物(II)和(III)可杀死细胞、抑制细胞增殖、抑制细胞生长、减弱细胞周期 G2 检查点和/或导致适应 G2 细胞周期停滞。提供了制造本发明化合物的方法。本发明提供了用于治疗细胞增殖障碍的取代唑二酮类化合物（II）和（III）。本发明包括取代的唑二酮(II)和(III)，用于选择性地杀死或抑制癌细胞，而无需额外的抗癌治疗。本发明包括细胞周期G2-检查点消减取代的唑二酮(II)和(III)，用于选择性地使癌细胞对DNA损伤试剂、治疗和/或其它类型的抗癌试剂敏感。
• N-SUBSTITUTED 2,5-DIOXO-AZOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
  申请人：CanBas Co., Ltd.

  公开号：EP3567035A1

  公开（公告）日：2019-11-13

  Novel substituted azole diones are provided that kill cells, suppress cell proliferation, suppress cell growth, abrogate the cell cycle G2 checkpoint and/or cause adaptation to G2 cell cycle arrest. Methods of making and using the invention compounds are provided. The invention provides substituted azole diones to treat cell proliferation disorders. The invention includes the use of substituted azole diones to selectively kill or suppress cancer cells without additional anti-cancer treatment. The invention includes the use of cell cycle G2-checkpoint-abrogating substituted azole diones to selectively sensitize cancer cells to DNA damaging reagents, treatments and/or other types of anti-cancer reagents.

  本发明提供了新型取代唑二酮类化合物，可杀死细胞、抑制细胞增殖、抑制细胞生长、减弱细胞周期 G2 检查点和/或导致细胞周期 G2 停滞。本发明还提供了制造和使用本发明化合物的方法。本发明提供了用于治疗细胞增殖障碍的取代唑二酮类化合物。本发明包括使用取代的唑二酮选择性地杀死或抑制癌细胞，而无需额外的抗癌治疗。本发明包括使用细胞周期G2-检查点抑制取代的唑二酮类化合物选择性地使癌细胞对DNA损伤试剂、治疗和/或其它类型的抗癌试剂敏感。
• US8084454B2
  申请人：——

  公开号：US8084454B2

  公开（公告）日：2011-12-27